Whalen Wealth Management »

Intra Cellular Therapies shares owned by Whalen Wealth Management

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Whalen Wealth Management from 13F filings

Historical chart of Whalen Wealth Management investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Whalen Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Whalen Wealth Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $219k 3.0k 73.17

More positions owned by Whalen Wealth Management

Ishares Tr Short Treas Bd (SHV)
Ishares Tr Fltg Rate Nt Etf (FLOT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Ishares Tr 0-5yr Invt Gr Cp (SLQD)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Ishares Tr Ibonds 29 Trm Ts (IBTJ)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Simplify Exchange Traded Fun Managed Futures (CTA)
Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
Global X Fds Glbl X Mlp Etf (MLPA)
Proshares Tr Short S&p 500 Ne
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr 0-5yr Hi Yl Cp (SHYG)

View all positions for Whalen Wealth Management

Top funds holding Intra Cellular Therapies

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Daniel D. Thurber
venBio Select Advisor
Invesco
Bellevue Group
State Street Corporation
Franklin Resources
ClearBridge Advisors
Geode Capital Management
Perceptive Advisors
Pictet Asset Management Holding SA
Deep Track Capital

View all funds holding Intra Cellular Therapies